ClinicalTrials.gov
public full text
Public Domain
A Study of LY3410738 in Healthy Adult Participants
The main purpose of this study is to assess the safety and tolerability of LY3410738 and to look at the amount of the study drug, LY3410738, that gets into the blood stream and how long it takes the body to get rid of it when given in healthy adult participants. For each participant, the total duration of the study will be 53 days, including screening.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes#862442
- A Study Comparing Different Formulations of LY3410738 in Healthy Adult Participants#908248
- A Study of LY3532226 in Healthy Participants#904852
- A Study of LY3867070 in Healthy Participants#910615
- A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus#868322
Record · ID 1137973
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive